Monte Rosa Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $119k | 22k | 5.30 |
| 2024-06-30 | $41k | 11k | 3.74 |
| 2024-03-31 | $94k | 13k | 7.05 |
| 2023-12-31 | $79k | 14k | 5.65 |
| 2023-09-30 | $67k | 14k | 4.79 |
| 2023-06-30 | $96k | 14k | 6.85 |
| 2023-03-31 | $205k | 26k | 7.79 |
| 2022-12-31 | $198k | 26k | 7.61 |
| 2022-09-30 | $193k | 24k | 8.21 |
| 2022-06-30 | $130k | 14k | 9.65 |
| 2022-03-31 | $212k | 16k | 13.22 |
| 2021-12-31 | $143k | 7.0k | 20.40 |
| 2021-09-30 | $171k | 7.7k | 22.24 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft